Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ipratropium Bromide in Peri-operative COPD
NCT01943552Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ipratropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2013; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01943552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01943552.